Skin Cancer Treatment Reimagined
Now there is a non-invasive treatment option for non-melanoma skin cancer. OncoPatch improves patient experience by using low-energy beta therapy. Get back to living with OncoPatch.
OncoPatch is applied directly to the lesion in a doctor’s office. It uses low-energy beta therapy and may require as little as one treatment.
How OncoPatch Works
OncoPatch is a non-invasive treatment for non-melanoma skin cancers, including basal and squamous cell carcinomas. OncoPatch uses low-energy beta therapy applied directly to the lesion. This type of therapy has a shallow penetration range, sparing the healthy tissue adjacent to the cancer and allowing for targeted treatment with minimal side effects.
OncoPatch can be administered by a physician and may require as little as one office visit.
Published literature on brachytherapy for non-melanoma skin cancer has shown favorable clinical outcomes. Clinical studies of OncoPatch are ongoing.
Non-Invasive
Easy to Administer
Patient Convenience
Spares Healthy Tissue
Transforming Non-Melanoma Skin Cancer Treatment
OncoPatch is well suited for cosmetically-sensitive and non-surgical candidates seeking treatment for non-melanoma skin cancer.
Better Patient Experience
OncoPatch treatment is non-invasive and may require as little as one application.
Fewer Complication Risks
Low-energy beta therapy allows for targeted treatment with minimal collateral damage to deeper tissues and no reconstruction needed.
Practice Efficiency
Clinics can perform more high-value treatments in less time without the need for capital investments or hiring specialized personnel.
Positive Clinical Studies
While clinical studies of OncoPatch are ongoing, published literature on the use of brachytherapy to treat non-melanoma skin cancer has shown favorable clinical outcomes with a well tolerated safety profile.
OncoPatch Team
At OncoPatch, our mission is to provide a non-invasive treatment for non-melanoma skin cancer using low-energy beta therapy. OncoPatch treatment offers an innovative solution that is more convenient for patients and may result in favorable cosmetic outcomes. Therapy can be delivered in a physician’s office in as little as one treatment visit.
Our team of physicists, medical physicists, and material scientists are dedicated to improving the lives of skin cancer patients through innovation and discovery. We are actively working with various business partners to develop this treatment technology and make it available to patients diagnosed with non-melanoma skin cancer as soon as possible.
David Westerly, PhD
Co-founder & CEO
Quentin Diot, PhD
Co-founder
Frederic Sarazin, PhD
Co-founder
Jeramy Zimmerman, PhD
Co-founder
Investing In The Future Of Skin Cancer Treatment
With the incidence of skin cancer growing in the U.S., OncoPatch seeks to offer a targeted, non-invasive treatment for non-melanoma skin cancers.
Multiple Funding Partners
OncoPatch research and development supported by:
- National Institutes of Health (NIH)
- Colorado Office of Economic Development and International Trade (CO-EDIT)
- CU Innovations
- Colorado School of Mines Foundation
- Cancer League of Colorado
- University of Colorado Cancer Center
Scalable Treatment Option
Adopting OncoPatch requires no capital investments, specialized facilities, or hiring additional personnel. Physicians can seamlessly integrate treatment into existing workflows, offering a high-value treatment to patients while improving access to care.
Addressing a Growing Need
Non-melanoma skin cancer is the most common cancer in the U.S., with incidence rising year over year. OncoPatch aims to expand access to non-invasive treatment options for patients who may not be candidates for surgery.
Frequently Asked Questions
What is low-energy beta therapy?
Low-energy beta therapy is a special type of radiation therapy that uses low-energy electrons (i.e., beta particles) for treatment. Unlike X-ray or gamma-ray therapies, which use penetrating forms of radiation and require lead or concrete-shielded treatment rooms, the electrons emitted from low-energy beta sources can be stopped with less than a half-inch of plastic. When applied to a patient’s skin cancer, these electrons deposit the vast majority of their energy in the first few millimeters of tissue, focusing the therapeutic effect on the cancer and sparing the healthy tissue underneath. This allows for targeted treatment to be delivered in as little as one session with minimal side effects.
Penetration difference between X-rays and low-energy beta particles used to treat non-melanoma skin cancer.
What types of skin cancer can OncoPatch treat?
Clinical investigations of OncoPatch are ongoing, however low-energy beta therapy has been used to treat basal cell and squamous cell carcinomas.
How are the patches applied to the skin?
The OncoPatch applicator is attached to the skin using a gentle-release silicon bandage. This applicator allows the dermatologist to precisely define the position of the treatment patch while also ensuring the patch is securely held in place for the duration of the treatment.
How can I partner with OncoPatch?
OncoPatch is dedicated to improving the lives of skin cancer patients through innovation and discovery. If you share our passion and are interested in partnering with us, contact us via the link on this website and we will reach out to you shortly.
